Z. Liu and L. A. Diaz, Bullous pemphigoid: end of the century overview, J Dermatol, vol.28, pp.647-50, 2001.

P. Bernard and F. Antonicelli, Bullous pemphigoid: a review of its diagnosis, associations and treatment, Am J Clin Dermatol, vol.18, pp.513-541, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01825913

Z. Liu, L. A. Diaz, J. L. Troy, A. F. Taylor, D. J. Emery et al., A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180, J Clin Invest, vol.92, pp.2480-2488, 1993.

M. Hirose, A. Recke, T. Beckmann, A. Shimizu, A. Ishiko et al., Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice, J Immunol, vol.187, pp.1176-83, 2011.

R. Chen, J. A. Fairley, M. Zhao, G. J. Giudice, D. Zillikens et al., but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation, J Immunol, vol.169, pp.3987-92, 2002.

S. Furudate, T. Fujimura, Y. Kambayashi, A. Kakizaki, and S. Aiba, Comparison of CD163 + CD206 + M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid, Dermatology (Basel), vol.229, pp.369-78, 2014.

M. Ståhle-bäckdahl, M. Inoue, G. J. Guidice, and W. C. Parks, 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen, J Clin Invest, vol.93, pp.2022-2052, 1994.

D. M. Mosser and J. P. Edwards, Exploring the full spectrum of macrophage activation, Nat Rev Immunol, vol.8, pp.958-69, 2008.

A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi et al., The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol, vol.25, pp.677-86, 2004.

F. O. Martinez, L. Helming, and S. Gordon, Alternative activation of macrophages: an immunologic functional perspective, Annu Rev Immunol, vol.27, pp.451-83, 2009.

S. Gordon, Alternative activation of macrophages, Nat Rev Immunol, vol.3, pp.23-35, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00474829

L. Cassetta, E. Cassol, and G. Poli, Macrophage polarization in health and disease, Sci World J, vol.11, pp.2391-402, 2011.

Y. Liu, X. Zou, Y. Chai, and Y. Yao, Macrophage polarization in inflammatory diseases, Int J Biol Sci, vol.10, pp.520-529, 2014.

I. A. Udalova, A. Mantovani, and M. Feldmann, Macrophage heterogeneity in the context of rheumatoid arthritis, Nat Rev Rheumatol, vol.12, pp.472-85, 2016.

J. P. Edwards, X. Zhang, K. A. Frauwirth, and D. M. Mosser, Biochemical and functional characterization of three activated macrophage populations, J Leukoc Biol, vol.80, pp.1298-307, 2006.

J. S. Gerber and D. M. Mosser, Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors, J Immunol, vol.166, pp.6861-6869, 2001.

L. Jan, S. Plée, J. Vallerand, D. Dupont, A. Delanez et al., Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid, J Invest Dermatol, vol.134, pp.2908-2925, 2014.

J. Plée, L. Jan, S. Giustiniani, J. Barbe, C. Joly et al., Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Sci Rep, vol.5, p.18001, 2015.

M. Riani, L. Jan, S. Plée, J. Durlach, A. et al., Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes, J Allergy Clin Immunol, vol.139, pp.863-72, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01754072

L. Vaillant, P. Bernard, P. Joly, C. Prost, B. Labeille et al., Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group, Arch Dermatol, vol.134, pp.1075-80, 1998.

J. Tjiu, J. Chen, C. Shun, S. Lin, Y. Liao et al., Tumorassociated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction, J Invest Dermatol, vol.129, pp.1016-1041, 2009.

H. Emonard and W. Hornebeck, Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation, Biol Chem, vol.378, pp.265-71, 1997.

P. Qiao, E. Dang, H. Fang, J. Zhang, B. Li et al., Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid, Oncotarget, vol.9, pp.35517-35544, 2018.

R. A. Musson, Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity, Am J Pathol, vol.111, pp.331-371, 1983.

A. Berer, J. Stöckl, O. Majdic, T. Wagner, M. Kollars et al., 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro, Exp Hematol, vol.28, pp.575-83, 2000.

S. Tedesco, D. Majo, F. Kim, J. Trenti, A. Trevisi et al., Convenience versus biological significance: are PMA-differentiated THP-1 cells a reliable substitute for blood-derived macrophages when studying in vitro polarization?, Front Pharmacol, vol.9, p.71, 2018.

H. Shiratori, C. Feinweber, S. Luckhardt, B. Linke, E. Resch et al., THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro, Mol Immunol, vol.88, pp.58-68, 2017.

N. Wang, H. Liang, and K. Zen, Molecular mechanisms that influence the macrophage m1-m2 polarization balance, Front Immunol, vol.5, p.614, 2014.

Z. Jiang and L. Zhu, Update on the role of alternatively activated macrophages in asthma, J Asthma Allergy, vol.9, pp.101-108, 2016.

B. Giacalone, D. 'auria, L. Bonifati, C. Ferraro, C. Riccardi et al., Decreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid. Opposite behavior of TNF-alpha, interleukin-4 and interleukin-10, Exp Dermatol, vol.7, pp.157-61, 1998.

F. Ameglio, D. 'auria, L. Bonifati, C. Ferraro, C. Mastroianni et al., Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity, Br J Dermatol, vol.138, pp.611-615, 1998.

E. Schmidt, B. Bastian, R. Dummer, H. Tony, E. Bröcker et al., Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid, Arch Dermatol Res, vol.288, pp.353-360, 1996.

S. H. Polukort, J. Rovatti, L. Carlson, C. Thompson, J. Ser-dolansky et al., IL-10 enhances IgE-mediated mast cell responses and is essential for the development of experimental food allergy in IL-10-deficient mice, J Immunol, vol.196, pp.4865-76, 2016.

E. Cozzani, G. Gasparini, D. Zenzo, G. Parodi, and A. , Immunoglobulin E and bullous pemphigoid, Eur J Dermatol, vol.28, pp.440-448, 2018.

S. Soldano, C. Pizzorni, S. Paolino, A. C. Trombetta, P. Montagna et al., Alternatively activated (M2) macrophage phenotype is inducible by Endothelin-1 in cultured human macrophages, PLoS ONE, vol.11, 2016.

A. Mantovani, S. K. Biswas, M. R. Galdiero, A. Sica, and M. Locati, Macrophage plasticity and polarization in tissue repair and remodelling, J Pathol, vol.229, pp.176-85, 2013.

S. K. Biswas, M. Chittezhath, I. N. Shalova, and J. Lim, Macrophage polarization and plasticity in health and disease, Immunol Res, vol.53, pp.11-24, 2012.

S. Hoffmann, M. Berneburg, and S. Schreml, Bullous pemphigoid associated with adalimumab therapy in a patient with ulcerative colitis, Case Rep Dermatol, vol.10, pp.145-153, 2018.

L. L. Wessman, E. K. Blixt, D. A. Wetter, and R. Y. Miest, Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis. JAAD Case Rep, vol.3, pp.339-380, 2017.

E. N. Wilmer, N. Becker, A. Chen, and G. Kroumpouzos, Etanerceptinduced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient, JAAD Case Rep, vol.2, pp.25-32, 2016.

L. Boussemart, S. Jacobelli, F. Batteux, C. Goulvestre, P. Grange et al., Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports, Dermatology (Basel), vol.221, pp.201-206, 2010.

M. Bordignon, A. Belloni-fortina, B. Pigozzi, M. Tarantello, and M. Alaibac, Bullous pemphigoid during long-term TNF-alpha blocker therapy, Dermatology (Basel), vol.219, pp.357-365, 2009.